Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Peripherin is a biomarker of axonal damage in peripheral nervous system disease.

Keddie S. et al, (2023), Brain, 146, 4562 - 4573

Ultrasensitive assay technology and fluid biomarkers for the evaluation of peripheral nerve disease.

Bellanti R. et al, (2023), J Neurol Neurosurg Psychiatry

Nodal-paranodal antibodies in HIV-immune mediated radiculo-neuropathies: Clinical phenotypes and relevance.

Moodley K. et al, (2023), J Peripher Nerv Syst

Reply: Peripherin is a biomarker of axonal damage in Guillain Barré syndrome: a pathophysiological annotation.

Keddie S. et al, (2023), Brain

AL amyloidosis presenting with isolated lumbosacral radiculoplexus neuropathy.

Bellanti R. et al, (2023), Pract Neurol

Utilising clinical parameters to improve the selection of nerve biopsy candidates.

Kopanidis P. et al, (2023), Intern Med J

Cerebrospinal Fluid Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré Syndrome.

Al-Hakem H. et al, (2023), Neurology

Long-term tactile hypersensitivity after nerve crush injury in mice is characterized by the persistence of intact sensory axons

Kim HW. et al, (2023), Pain

Contactin-1 links autoimmune neuropathy and membranous glomerulonephritis

FEHMI J. et al, (2023), PLoS One

Antineurofascin IgG2-associated paediatric autoimmune nodopathy

Harris RE. et al, (2023), Developmental Medicine and Child Neurology

Guillain-Barré syndrome following Zika virus infection is associated with a diverse spectrum of peripheral nerve reactive antibodies

DAVIES AJ. et al, (2022), Neurology, Neuroimmunology and Neuroinflammation

TACROLIMUS-INDUCED CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPA- THY (CIDP): A CASE SERIES

Evans M. et al, (2022), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 93

An International Perspective on Preceding Infections in Guillain-Barré Syndrome: The IGOS-1000 Cohort.

Leonhard SE. et al, (2022), Neurology

INTER-LABORATORY VALIDATION OF NODAL/PARANODAL ANTIBODY TESTING

Rinaldi S. et al, (2022), JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 27, S154 - S155

MYELINATED HUMAN SENSORY NEURONS PROVIDE A PLATFORM FOR THE REPRODUCIBLE SCREENING OF PERIPHERAL NERVE-REACTIVE AUTOANTIBODIES IN PATIENT SERA

Fehmi J. et al, (2022), JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 27, S33 - S34

PERSISTENCE OF INTACT SENSORY AFFERENTS AND MYELIN THINNING CORRELATES WITH LONG-TERM HYPERSENSITIVITY AFTER PARTIAL CRUSH OF THE PERIPHERAL NERVE

Kim HW. et al, (2022), JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 27, S33 - S33

Schwann cell nodal membrane disruption triggers bystander axonal degeneration in a Guillain-Barré syndrome mouse model.

McGonigal R. et al, (2022), J Clin Invest

Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values.

Arends S. et al, (2022), Clin Neurophysiol, 138, 231 - 240

International validation of the Erasmus GBS Respiratory Insufficiency Score.

Doets AY. et al, (2022), Ann Neurol

Factors associated with the severity of COVID-19 outcomes in people with neuromuscular diseases: Data from the International Neuromuscular COVID-19 Registry

Pizzamiglio C. et al, (2022), European Journal of Neurology

Load More

1
2
3
4
5

Include forthcoming?